Poster Presentation ASSCR, AGCTS, ISCT ANZ and Friends Joint Scientific Conference 2019

Advancing the therapeutic potential of lentiviral β-globin gene therapy with selective decrease of α2-globin mRNA expression (#226)

Jim Vadolas 1 , Tiwaporn Nualkaew 2 3 , Brad McColl 2 , Astrid Glaser 2 , Suthat Fucharoen 3 , Saovaros Svasti 3 , Philippe Leboulch 4 5 , Emmanuel Payen 5 6
  1. Centre of Cancer Research, Hudson Institute of Medical Research, Melbourne, VIC, Australia
  2. Cell and Gene Therapy Research group, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia
  3. Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhonpathom, Thailand
  4. Genetics Division, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA, USA
  5. INSERM, Paris, France
  6. CEA François Jacob Biology Institute, Division of Innovative Therapies and UMR E007, University Paris-Saclay, Fontenay-aux-Roses, France
Publish consent withheld
  • Have you presented your abstract at another international meeting?: